ReviewOncology reviews2025

Lights and shades of front-line treatment with covalent BTK inhibitors combined with venetoclax in patients with chronic lymphocytic leukemia.

Andrea Visentin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.